新生儿听力与聋病易感基因联合筛查及干预管理系统在听力筛查中的应用价值  

Application value of neonatal hearing and deafness-susceptibility genes screening and intervention management system in hearing screening

作　　者：蓝英[1] 胡敏[1] 何玮[1] 赵世杰[1] 梁兴明[1] 杨强威 

机构地区：[1]广西南宁市第二人民医院耳鼻咽喉科,南宁市530031

出　　处：《广西医学》2016年第11期1571-1573,共3页Guangxi Medical Journal

基　　金：广西南宁市科学研究与技术开发计划(201109052C)

摘　　要：目的 探讨新生儿听力与聋病易感基因联合筛查及干预管理系统在听力筛查中的应用价值。方法 2005~2015年使用新生儿听力与聋病易感基因联合筛查及干预管理系统前后进行听力筛查的新生儿分别为25 805例、3 106例,比较使用该系统前后新生儿听力筛查的初筛率、复筛率、初筛通过率、复筛通过率、转诊率的差异。结果 应用该系统后,新生儿听力筛查的初筛率、复筛率明显提高（P〈0.05）。结论 新生儿听力与聋病易感基因联合筛查及干预管理系统的应用显著提高了新生儿听力筛查的复筛率,减少了失访人数,提高了听力筛查的工作效率,有利于聋病患儿进行早期预防和干预治疗。Objective To explore the application value of neonatal hearing and deafness-susceptibility genes screening and intervention management system in hearing screening. Methods From 2005 to 2015, the numbers of neonates undergoing hearing screening before and after application of neonatal hearing and deafness-susceptibility genes screening and intervention management system were 25 805 and 3 106 respectively. The first screening rate, re-screening rate, pass rate for first screening, pass rate for re-screening and referral rate of the neonates before and after the application of the System were compared. Results After the application of the system, the first screening rate and re-screening rate increased significantly （ P 〈 0.05 ）. Conclusion The application of neonatal hearing and deafness-susceptibility genes screening and intervention management system can significantly increase the re-screening rate of neonatal hearing screening and reduce the number of patients with loss to follow-up,and improves the work efficiency of the hearing screening,which is benefit for early prevention and intervention in children with hearing loss.

关 键 词：听力筛查 新生儿 复筛率 随访 管理系统 

分 类 号：R722.1[医药卫生—儿科] R764.43[医药卫生—临床医学]